Hyperion Defi (HYPD) Profit After Tax (2017 - 2026)
Hyperion Defi (HYPD) posted quarterly Profit After Tax of $8.8 million for Q1 2026, up 353.78% year-over-year from $1.9 million in Q1 2025, and up 122.24% quarter-over-quarter from -$39.8 million in Q4 2025.
Hyperion Defi (HYPD) Profit After Tax (2017 - 2026) Analysis & Trends
Hyperion Defi (HYPD) has reported Profit After Tax for 10 consecutive years, with $8.8 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Profit After Tax rose 353.78% year-over-year to $8.8 million; the TTM figure through Mar 2026 stood at -$33.0 million (up 22.16% YoY), while the FY2025 annual figure was -$45.3 million, up 9.04% from the prior year.
- Profit After Tax advanced to $8.8 million in Q1 2026 per HYPD's latest filing, from -$39.8 million in the prior quarter.
- Across five years, Profit After Tax topped out at $8.8 million in Q1 2026 and bottomed at -$39.8 million in Q4 2025.
- Historically, Profit After Tax has averaged -$8.4 million across 5 years, with a median of -$7.4 million in 2022.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 277.34% — and 2026, when it soared 353.78%.
- Hyperion Defi's Profit After Tax stood at -$5.1 million in 2022, then plunged by 56.03% to -$7.9 million in 2023, then tumbled by 151.22% to -$19.9 million in 2024, then tumbled by 99.39% to -$39.8 million in 2025, then soared by 122.24% to $8.8 million in 2026.
- Business Quant data shows HYPD's Profit After Tax at $8.8 million in Q1 2026, -$39.8 million in Q4 2025, and $6.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Hyperion Defi | 44.93 Mn | 35.29 Mn | 357,693.00 | 30.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 30.95 Mn |
| Mar 31, 2026 | 8.84 Mn |
| Dec 31, 2025 | -39.75 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | -8.69 Mn |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | -19.94 Mn |
| Sep 30, 2024 | -7.89 Mn |
| Jun 30, 2024 | -11.05 Mn |
| Mar 31, 2024 | -10.92 Mn |
| Dec 31, 2023 | -7.94 Mn |
| Sep 30, 2023 | -6.99 Mn |
| Jun 30, 2023 | -8.33 Mn |
| Mar 31, 2023 | -5.91 Mn |
| Dec 31, 2022 | -5.09 Mn |
| Sep 30, 2022 | -7.41 Mn |
| Jun 30, 2022 | -7.27 Mn |
| Mar 31, 2022 | -7.33 Mn |
| Dec 31, 2021 | 2.87 Mn |
| Sep 30, 2021 | -6.04 Mn |